Concepedia

Author

Onofre Sanmartín

Fundación Instituto Valenciano de Oncología

Also Known As

O. Sanmartín, ONOFRE SANMARTIN, ONOFRE SANMARTÍN, Onofre SANMARTÍN, Onofre SanMartin, Onofre Sanmartin, Onofre SanmartÍN, Onofre Sanmartín

122

Publications

2.6K

Citations

26

H-Index

47

Concepts

All Affiliations

Fundación Instituto Valenciano de OncologíaValencia Catholic University Saint Vincent MartyrUniversitat de ValènciaHospital Universitario Fundación Jiménez DíazGerman Cancer Research Center
OS

About

Onofre Sanmartín is an author at Fundación Instituto Valenciano de Oncología specializing in medicine, dermatology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

14

18

558

2

Public Health

1

1

18

3

Anatomy

1

1

14

4

Cell Biology

1

1

22

5

Head And Neck Surgery

1

1

14

Onofre Sanmartín

×

45

Publications

1.6K

Citations

23

H-Index

YearCitations

Dermatofibrosarcoma protuberans: A clinicopathological, immunohistochemical, genetic (COL1A1-PDGFB), and therapeutic study of low-grade versus high-grade (fibrosarcomatous) tumors

B. Llombart, Carlos Monteagudo, Onofre Sanmartín,

Journal of the American Academy of Dermatology

2011

129

Dermatofibrosarcoma protuberans: clinical, pathological, and genetic (<i>COL1A1‐PDGFB </i>) study with therapeutic implications

B. Llombart, Onofre Sanmartín, José Antonio López‐Guerrero,

Histopathology

2009

101

Molecular diagnosis of dermatofibrosarcoma protuberans: A comparison between reverse transcriptase‐polymerase chain reaction and fluorescence in situ hybridization methodologies

Rocío Salgado, B. Llombart, Ramón M. Pujol,

Genes Chromosomes and Cancer

2011

96

Cutaneous Infection with Mycobacterium fortuitum after Localized Microinjections (Mesotherapy) Treated Successfully with a Triple Drug Regimen

Eduardo Nagore, Pilar Ramos, Rafael Botella‐Estrada,

Acta Dermato Venereologica

2001

83

A randomized pilot comparative study of topical methyl aminolevulinate photodynamic therapy versus imiquimod 5% versus sequential application of both therapies in immunocompetent patients with actinic keratosis: Clinical and histologic outcomes

C. Serra‐Guillén, Eduardo Nagore, L. Hueso,

Journal of the American Academy of Dermatology

2012

80

New basal cell carcinoma susceptibility loci

Simon Stacey, Hannes Helgason, Sigurjón A. Guðjónsson,

Nature Communications

2015

74

Frequent <i>DPH3</i> promoter mutations in skin cancers

Evgeniya Denisova, Barbara Heidenreich, Eduardo Nagore,

Oncotarget

2015

71

Correlation Between Preoperative Magnetic Resonance Imaging and Surgical Margins with Modified Mohs for Dermatofibrosarcoma Protuberans

C. Serra‐Guillén, Onofre Sanmartín, B. Llombart,

Dermatologic Surgery

2011

61

Germline sequence variants in TGM3 and RGS22 confer risk of basal cell carcinoma

Simon Stacey, Patrick Sulem, Daníel F. Guðbjartsson,

Human Molecular Genetics

2014

57

Chemotherapy-related bilateral dermatitis associated with eccrine squamous syringometaplasia: Reappraisal of epidemiological, clinical, and pathological features

Antonio Martorell, Onofre Sanmartín, Rafael Botella‐Estrada,

Journal of the American Academy of Dermatology

2011

50

Page 1